Literature DB >> 19398045

BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells.

M V Bais1, N Wigner, M Young, R Toholka, D T Graves, E F Morgan, L C Gerstenfeld, T A Einhorn.   

Abstract

The effects of BMP2 on bone marrow stromal cell differentiation and bone formation after bone marrow ablation were determined using C57 BL/6J (B6) mice. Inhibition of BMP2 expression with lentiviral BMP2 shRNA prevented both mineralized nodule formation in vitro and bone formation in vivo, and blocked the expression of Runx2 and osterix, transcriptional determinants of terminal osteogenic differentiation. No effect was observed on the expression of Sox9, a transcription factor, which is the one of the first transcriptional determinant to be expressed in committed chondroprogenitor and osteoprogenitor cells. In vitro studies showed that exogenously added BMP7 rescued the expression of osterix and enhanced the expression of Sox9, but had no effect on the expression of Runx2, while it only partially recovered the development of mineral deposition in the cultures. On the other hand, the exogenous addition of BMP2 rescued both Runx2 and osterix expression, did not enhance the expression of Sox9, but fully recovered the inhibition of mineral deposition in the cultures. Using antibodies against CD146 and Sox9, immunohistological examination of the cell populations found in the medullary space three days after bone marrow ablation, showed qualitatively equal numbers of cells expressing these skeletal progenitor and stem cell markers in control and BMP2 shRNA treated animals. Fluorescence Activated Cell Sorting (FACS) analysis of the cells found with the marrow cavities at three days after marrow ablation using CD146 antibody showed near equal numbers of immunopositive cells in both control and shRNA treated animals. In summary, the differences observed in vitro for BMP2 and BMP7 on osteogenic gene expression and mineralization suggest that they have differing effects on bone cell differentiation. These results further demonstrate that in vivo BMP2 is a central morphogenetic regulator of post natal osteoprogenitor differentiation, but does not affect recruitment of progenitors to the osteoblastic lineage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398045      PMCID: PMC2745982          DOI: 10.1016/j.bone.2009.04.239

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  53 in total

1.  Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation.

Authors:  M Dodig; T Tadic; M S Kronenberg; S Dacic; Y H Liu; R Maxson; D W Rowe; A C Lichtler
Journal:  Dev Biol       Date:  1999-05-15       Impact factor: 3.582

2.  Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.

Authors:  L C Yeh; M L Adamo; M S Olson; J C Lee
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

Review 3.  Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects.

Authors:  M F Termaat; F C Den Boer; F C Bakker; P Patka; H J Th M Haarman
Journal:  J Bone Joint Surg Am       Date:  2005-06       Impact factor: 5.284

4.  Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors.

Authors:  Haruhiko Akiyama; Jung-Eun Kim; Kazuhisa Nakashima; Gener Balmes; Naomi Iwai; Jian Min Deng; Zhaoping Zhang; James F Martin; Richard R Behringer; Takashi Nakamura; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.

Authors:  Ayse B Celil; Phil G Campbell
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

6.  Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.

Authors:  Wei Zhu; Bernard A Rawlins; Oheneba Boachie-Adjei; Elizabeth R Myers; Jun Arimizu; Eugene Choi; Jay R Lieberman; Ronald G Crystal; Chisa Hidaka
Journal:  J Bone Miner Res       Date:  2004-08-30       Impact factor: 6.741

7.  Astrocyte differentiation mediated by LIF in cooperation with BMP2.

Authors:  K Nakashima; M Yanagisawa; H Arakawa; T Taga
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

8.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration.

Authors:  J O Hollinger; J M Schmitt; D C Buck; R Shannon; S P Joh; H D Zegzula; J Wozney
Journal:  J Biomed Mater Res       Date:  1998

9.  Mice lacking Bmp6 function.

Authors:  M J Solloway; A T Dudley; E K Bikoff; K M Lyons; B L Hogan; E J Robertson
Journal:  Dev Genet       Date:  1998

10.  Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.

Authors:  T Ebisawa; K Tada; I Kitajima; K Tojo; T K Sampath; M Kawabata; K Miyazono; T Imamura
Journal:  J Cell Sci       Date:  1999-10       Impact factor: 5.285

View more
  39 in total

1.  Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration.

Authors:  Manish V Bais; Zabrina M Shabin; Megan Young; Thomas A Einhorn; Darrell N Kotton; Louis C Gerstnefeld
Journal:  Biochem Biophys Res Commun       Date:  2011-11-28       Impact factor: 3.575

Review 2.  A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.

Authors:  Anna J Studwell; Darrell N Kotton
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

3.  Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.

Authors:  Mussadiq Iftikhar; Paola Hurtado; Manish V Bais; Nate Wigner; Danielle N Stephens; Louis C Gerstenfeld; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Mouse models of bone healing: fracture, marrow ablation, and distraction osteogenesis.

Authors:  Kyle Lybrand; Beth Bragdon; Louis Gerstenfeld
Journal:  Curr Protoc Mouse Biol       Date:  2015-03-02

Review 5.  Advanced BMP gene therapies for temporal and spatial control of bone regeneration.

Authors:  C G Wilson; F M Martín-Saavedra; N Vilaboa; R T Franceschi
Journal:  J Dent Res       Date:  2013-03-28       Impact factor: 6.116

6.  The biology of fracture healing.

Authors:  Richard Marsell; Thomas A Einhorn
Journal:  Injury       Date:  2011-04-13       Impact factor: 2.586

7.  Orthotopic non-metastatic and metastatic oral cancer mouse models.

Authors:  Manish V Bais; Maria Kukuruzinska; Philip C Trackman
Journal:  Oral Oncol       Date:  2015-02-11       Impact factor: 5.337

8.  Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis.

Authors:  Hidenori Matsubara; Daniel E Hogan; Elise F Morgan; Douglas P Mortlock; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2012-02-25       Impact factor: 4.398

9.  Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.

Authors:  Mona Alsulaiman; Manish V Bais; Philip C Trackman
Journal:  J Cell Commun Signal       Date:  2015-12-01       Impact factor: 5.782

10.  Signaling pathways implicated in androgen regulation of endocortical bone.

Authors:  Kristine M Wiren; Anthony A Semirale; Joel G Hashimoto; Xiao-Wei Zhang
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.